BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2825867)

  • 1. Evolution of peripheral nerve function in hypoxaemic COPD patients taking almitrine bismesylate: a prospective long-term study.
    Lerebours G; Senant J; Moore N; Arnaud F; David P; Ozenne G; Nouvet G
    Bull Eur Physiopathol Respir; 1987 Aug; 23 Suppl 11():203s-206s. PubMed ID: 2825867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long term studies on almitrine bismesylate in COPD patients.
    Bourgouin-Karaouni D; Mercier J; Prefaut C
    Eur J Respir Dis Suppl; 1986; 146():695-701. PubMed ID: 3096767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Almitrine bismesylate: a long-term placebo-controlled double-blind study in COAD--Vectarion International Multicentre Study Group.
    Voisin C; Howard P; Ansquer JC
    Bull Eur Physiopathol Respir; 1987 Aug; 23 Suppl 11():169s-182s. PubMed ID: 3318971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ten cases of peripheral neuropathy during treatment with almitrine in COPD patients.
    Gerard M; Leger P; Couturier JC; Robert D
    Eur J Respir Dis Suppl; 1986; 146():591-6. PubMed ID: 3023128
    [No Abstract]   [Full Text] [Related]  

  • 5. Beneficial effects of almitrine bismesylate on pulmonary gas exchange in COPD.
    Melot C; Naeije R; Hallemans R; Mols P; Lejeune P
    Eur J Respir Dis Suppl; 1983; 126():249-54. PubMed ID: 6586439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Almitrine: a peripheral respiratory stimulant in chronic obstructive pulmonary disease].
    Rubio Terrés C; López Alvarez M; Vargas Castrillón E
    Rev Clin Esp; 1990 Feb; 186(2):84-7. PubMed ID: 2158666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Peripheral neuropathy in chronic bronchopathy. A study of 128 patients].
    Lerebours G; Nouvet G; Senant J; Moore N; Arnaud F
    Prax Klin Pneumol; 1988 Jun; 42 Suppl 1():400-2. PubMed ID: 2902611
    [No Abstract]   [Full Text] [Related]  

  • 8. [Neuropathies and almitrine. 14 cases].
    Petit H; Leys D; Hurtevent JF; Parent M; Caron J; Salomez JL; Krivosic I
    Rev Neurol (Paris); 1987; 143(6-7):510-9. PubMed ID: 2889253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vectarion International Multicentre Study (VIMS): a long term double blind placebo controlled trial in COLD patients.
    Sadoul P
    Eur J Respir Dis Suppl; 1983; 126():357-61. PubMed ID: 6373344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pattern of breathing and gas exchange following oral almitrine bismesylate in patients with chronic obstructive pulmonary disease.
    Stradling JR; Nicholl CG; Cover D; Davies EE; Hughes JM; Pride NB
    Eur J Respir Dis Suppl; 1983; 126():255-64. PubMed ID: 6373340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of almitrine bismesylate on chemosensitivity in patients with chronic airways obstruction.
    Stanley NN; Pieczora JA; Pauly N
    Eur J Respir Dis Suppl; 1983; 126():233-7. PubMed ID: 6426992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pulmonary hemodynamic monitoring in chronic respiratory insufficiency treated with almitrine bismesilate for 4 months in a double-blind study].
    Bourgouin-Karaouni D; Ramonatxo M; Michel FB; Macabies J; Prefaut C
    Rev Mal Respir; 1984; 1(4):245-50. PubMed ID: 6505362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effects of almitrine bismesylate on oxygenation during wakefulness and sleep in chronic obstructive pulmonary disease.
    Gothe B; Cherniack NS; Bachand RT; Szalkowski MB; Bianco KA
    Am J Med; 1988 Mar; 84(3 Pt 1):436-44. PubMed ID: 2894764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia, almitrine, and peripheral neuropathy.
    Howard P
    Thorax; 1989 Apr; 44(4):247-50. PubMed ID: 2548298
    [No Abstract]   [Full Text] [Related]  

  • 15. [Almitrine bismesylate. A peripheral chemoreceptor agonist].
    Nielsen SP
    Ugeskr Laeger; 1988 Nov; 150(46):2797-800. PubMed ID: 2905090
    [No Abstract]   [Full Text] [Related]  

  • 16. [Sequential administration of a reduced dose of almitrine to patients with chronic obstructive bronchopneumopathies. A controlled multicenter study].
    Weitzenblum E; Arnaud F; Bignon J; Boutin C; Brune J; Castaing Y; Courty G; Derenne J; Duroux P; Fréour P
    Rev Mal Respir; 1992; 9(4):455-63. PubMed ID: 1509190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sensorimotor polyneuropathy induced by almitrine dimesylate. Anatomo-clinical study of a case].
    Rousseau JJ; Lust CA; Brucher JM
    Acta Neurol Belg; 1987; 87(4):197-206. PubMed ID: 2890254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential treatment with low dose almitrine bismesylate in hypoxaemic chronic obstructive airways disease.
    Bardsley PA; Howard P; Tang O; Empey D; Harrison B; Peake MD; O'Reilly J; Riordan JF; Wilkinson J; Arnaud F
    Eur Respir J; 1992 Oct; 5(9):1054-61. PubMed ID: 1426214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of the carotid body on gas exchange during exercise.
    Grassi C; Cerveri I; Rampulla C; Tantucci C; Grassi V
    Bull Eur Physiopathol Respir; 1987 Aug; 23 Suppl 11():191s-194s. PubMed ID: 3690031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Peripheral axonic neuropathy during treatment with almitrine bismesylate (Vectarion). Possible role of wasting].
    Gherardi R; Louarn F; Perrier M; Eizenbaum JF
    J Toxicol Clin Exp; 1985; 5(6):393-7. PubMed ID: 2878072
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.